Anti-NKG2D-ligand NK-cell therapy (The Third Affiliated Hospital of Guangzhou Medical University)
N/A
Report date: 2022/01/14 13:23:58
Base Information
Drug NameAnti-NKG2D-ligand NK-cell therapy (The Third Affiliated Hospital of Guangzhou Medical University)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe Third Affiliated Hospital Of Guangzhou Medical University
China Registration ClassN/A
Develop Information
Active CompaniesThe Third Affiliated Hospital Of Guangzhou Medical University
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A